Frank Groenewegen

Frank Groenewegen is a Co-Founder and General Partner of 415C. He brings almost 40 years of investing, management, sales & marketing experience in the medical technology space, the last 30 years as serial investor and entrepreneur. As an investor, Frank has funded over 40 companies. As an entrepreneur, he has founded, built, and exited several successful European medical device distribution companies, including CoRRect Medical (acquired by Uniphar PLC in 2021), Regis Medical GmbH (merged with CoRRect Medical), Ovum Ventures GmbH (“CoreValve” acquired by Medtronic in 2009) and Cardiologic GmbH (acquired by Boston Scientific in 2002). His companies have commercialized dozens of innovative medical device technologies in Europe and helped establish new clinical standards of care, including cerebral embolic protection, transcatheter aortic valve replacement (TAVR), ultrasound renal denervation, and the world’s first pre-mounted coronary stents (Arterial Vascular Engineering).

Following Boston Scientific’s acquisition of Cardiologic GmbH, Frank served as the General Manager of Boston Scientific’s Interventional Cardiology Division Germany. Previously, he held several management positions at St. Jude Medical (now part of Abbott), W. L. Gore & Associates, and AHSC American Hospital Supply Corp. (now part of Baxter).